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Kidney protection against autoreactive CD8 T cells distinct models of these diseases [3, 4] has been known for a
from immunoprivilege and sequestration. long time. However, only a few animal models have been
Background. The kidney tubulointerstitium has been re- available to study T-cell–mediated tubulointerstitial ne-ported to be protected from T-cell–mediated damage by se-
phritis. Thus, there is limited direct experimental evidencequestration from the T-cell compartment. We examined the
for an effector role of T cells in the pathogenesis of kidneyability of autoreactive T cells to infiltrate the kidney in a trans-
genic mouse model. diseases. The best analyzed model is the anti-renal tubular
Methods. RIP-mOVA transgenic mice express the model basement membrane (TBM) model, which is character-
autoantigen, membrane-bound ovalbumin (mOVA), in kidney ized by tubulointerstitial infiltration in SJL mice after im-proximal tubular cells and pancreatic  cells. OVA-specific
munization with TBM [5, 6]. In this model, Lyt-2 T cellsCD8 T cells (OT-I cells) were transferred into these recipient
(CD8T cells in the current terminology) were identifiedmice and their immune response against pancreas and kidney
tissue was compared. as mediators of kidney disease [6]. However, Lyt-2 T
Results. When OVA-specific CD8 T cells (OT-I cells) were cells from nephritic SJL mice transferred by intravenous
injected into RIP-mOVA mice, they were activated in the renal injection into susceptible recipients failed to infiltrate
and pancreatic lymph nodes by cross-presentation. These in
the kidneys [5, 7]. Later, a similar observation was madevivo-activated OT-I cells caused the destruction of pancreatic
in transgenic mice expressing the viral protein HBsAgislets leading to autoimmune diabetes, but did not infiltrate
the kidney. Neither CD95–CD95 ligand interactions, which in several tissues, including the proximal kidney tubules
have been proposed to induce apoptosis in T cells infiltrating and the liver. Intravenous injection of cells from an
immunologically privileged sites, nor CD30 signaling was re- HBsAg-specific CD8 T-cell line resulted in autoimmune
sponsible for the lack of kidney infiltration. When OT-I cells
hepatitis, but not in nephritis [8]. However, localizedwere activated in vitro prior to injection, they could infiltrate
tubulointerstitial infiltration was observed in both mod-the kidney and caused acute renal failure when injected in high
numbers. els, when tubular antigen-specific T cells were injected
Conclusions. A mechanism distinct from previously described under the kidney capsule [7, 8]. These findings were
organ-specific protective mechanisms such as sequestration of interpreted as a form of sequestration of kidney tubules
antigen or CD95-mediated immunoprivilege contributes to the
from the CD8 T-cell compartment, due to physical bar-protection of the kidney tubulointerstitium from infiltration by
riers such as the dense TBM, which surrounds the tubulesautoreactive CD8 T cell.
completely, or the vascular endothelium and its own base-
ment membrane [8]. Damaging these barriers, for exam-
The close correlation of tubulointerstitial kidney infil- ple, by subcapsular injection, which involves transrenal
tration, particularly involving T cells, with the loss of renal puncture, was thought to allow CD8 T cells entrance
function in many human diseases [1, 2] and in animal into the tubulointerstitial compartment. Based on these
findings, it was proposed that undamaged kidney tubules
are relatively immune-privileged [6, 8].Key words: tubulointerstitial infiltration, transgenic mice, membrane-
The classic immunoprivileged sites are the testis andbound ovalbumin, renoprotection, tubular basement membrane, proxi-
mal tubules, diabetes, glucosuria. the anterior chamber of the eye. Several mechanisms
have been proposed to contribute to immunological priv-Received for publication November 28, 2000
ilege, many of them being variations of anatomical orand in revised form February 21, 2001
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histocompatibility complex (MHC) molecule expression with RAG-1 knockout mice to prevent the rearrange-
levels. Recently, a new protective mechanism has been ment of the transgenic T-cell receptor and to pre-
proposed to operate in the eye and the testis, which is clude generation of CD4 T cells and B cells in these
not based on prevention of T-cell entry, but on deletion animals [15]. RIP-mOVA mice, OT-I.CD30, OT-I.129,
of infiltrating cells. CD95L (Fas ligand), a member of and OT-I.lpr mice were described recently [15, 17, 18].
the tumor necrosis factor (TNF) molecule family, which In the present study, RIP-mOVA mice on a C57/B6
is expressed in these organs, was suggested to induce apo- background between 8 and 16 weeks of age were used.
ptosis in infiltrating T cells, thus protecting these tissues
In vitro activation and adoptive transferfrom rejection after organ grafting [9]. Some groups,
of OT-I cellshowever, have been unable to reproduce these findings.
Furthermore, organ grafts expressing transgenic CD95L OT-I RAG/ cells were prepared as described [15]
were found to be proinflammatory, but not protected by treatment of LN and spleen cells with anti-heat stable
against T-cell–mediated damage, so that the question of antigen (clone J11d) culture supernatant and rabbit com-
a molecular basis of immunological privilege remains plement. Activated OT-I cells were generated by incu-
controversial [10–12]. Nevertheless, in vitro CD95L ex- bating 1  106 OT-I cells for five days with 50  106
pression has also been described for kidney proximal 1500 cGy-irradiated spleen cells pulsed with 1 nmol/L
tubular cells [13, 14], suggesting that this mechanism also of the OVA-peptide SIINFEKL (provided by Dr. J. Fec-
might operate in the kidney. A clear role for CD95L ondo, Swinburne University of Technology, Hawthorn,
in controlling CD8 T-cell infiltration into the kidney, VIC, Australia). Purity of cells as determined by FACS
however, has not yet been demonstrated. staining was between 95 and 98% of live cells.
The present study investigated the ability of autoreac-
tive CD8 T cells to infiltrate the kidney proximal tu- Histology
bules in the transgenic RIP-mOVA model. From this Histology was performed by hematoxylin and eosin
model, we used two transgenic lines: RIP-mOVA mice, staining of sections of Bouin’s fixed tissue samples em-
which express a model antigen, membrane-bound oval- bedded in paraffin using standard methods. Double
bumin (OVA), in the pancreatic islet  cells and the immunohistology on frozen sections was performed as
proximal kidney tubular cells; and OT-I T cell receptor- described [15] using anti-CD8 supernatant (53.6.72 hy-
transgenic mice, which produce large numbers of naive bridoma), and was revealed by anti-rat Ig-Texas Red
OVA-specific CD8 T cells (OT-I cells). Importantly, (Pharmingen, San Diego, CA, USA). OVA expression
the naive phenotype of OT-I cells allows the investiga- was detected by rabbit anti-OVA antiserum, obtained
tion of their primary activation by tubular/pancreatic
by immunizing rabbits with whole OVA grade V (Sigma,autoantigen. This had not been possible in previous mod-
St. Louis, MO, USA) and revealed by anti-rabbit IgG-els using T-cell lines because such lines are generally
FITC (Pharmingen).maintained in an activated state in vitro. Using the RIP-
Assessment of the tubulointerstitial infiltrate was per-mOVA model, we have recently shown that naive CD8
formed as described [19] by examination of multipleT cells specific for a tubular self-antigen can be activated
longitudinal kidney sections in a group-blind fashion andin the renal lymph nodes (LNs) by specialized profes-
was graded (mean  SEM) according to the extent ofsional antigen-presenting cells (APCs), which can capture
cortical infiltration with mononuclear cells (MNCs) onantigen expressed in nonlymphatic tissues such as the kid-
a scale from 0 to 4 (0  normal; 1  small focal areasney and present it in an MHC class I-restricted manner
in 5% of the cortex; 2  MNCs surrounding tubular[15]. This form of activation, which was termed cross-
cells in 20% of the cortical area; 3  20 to 50%, andpresentation, first leads to proliferation, but then to the
4  involvement of 50% of the cortex).deletion of OT-I cells [16]. Autoimmune diabetes only
ensued when unphysiologically high numbers of OT-I Terminal deoxynucleotidyl transferase-mediated
cells were used. Such numbers could induce sufficient dUTP nick end labeling staining for the
pancreatic islet damage before they were deleted. In the
detection of apoptotic cell deathpresent study, we examined the effector phase of OT-I
In situ detection of cell death was performed usingcells against the proximal tubules of RIP-mOVA mice.
terminal deoxynucleotidyl transferase-mediated dUTP
nick end labeling (TUNEL), as described [20]. Briefly,
METHODS using 4	m sections of formaldehyde-fixed tissue, nuclear
Mice proteins were stripped using proteinase K, and the slides
were then incubated with terminal deoxynucleotidylAll mice were bred and maintained at the animal facili-
transferase (Pharmacia, Freiburg, Germany) and biotin-ties of the Medizinische Hochschule (Hannover, Ger-
14-dATP (Life Technologies, Eggenstein, Germany). In-many). All animal experiments were approved by the
local review board in Hannover. OT-I mice were crossed corporated biotinylated adenosine 5
-triphosphate (ATP)
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Fig. 1. The kidney tubulointerstitium is bet-
ter protected from infiltration by autoreactive
CD8 T cells than pancreatic islets. Ten 106
naive ovalbumin (OVA)-specific CD8T cells
(OT-I; A–D), OT-I.129 cells (E and F ), or
fas-deficient OT-I.lpr (G and H ) cells were
injected intravenously into RIP-mOVA mice
(C–H) or nontransgenic littermate mice (A
and B). As soon as glucosuria was detected
in RIP-mOVA mice (between days 6 and 8
after injection), the recipients were sacrificed
and pancreas (A, C, E, and G) and kidney (B,
D, F, and H) paraffin sections were stained for
HE. Arrows in F indicate areas of lymphocytic
infiltration. Magnification 200.
was detected using the ABC kit (Vector, Burlingame, genic OT-I line are injected into RIP-mOVA mice, they
always induce autoimmune diabetes when 5  106 cellsCA, USA) and 3,3
-diaminobenzidine. Negative controls
included omission of biotin-14ATP, in which case no or more are transferred [16]. To investigate whether
nuclear staining could be detected. Slides were counter- these cells can also induce autoimmune nephritis, kidney
stained with hematoxylin. sections of RIP-mOVA mice, injected with of 5  106
naive OT-I cells, were examined histologically. On day
7 after the adoptive transfer, destruction of pancreaticRESULTS
islets (Figs. 1C) and autoimmune diabetes were evident,
Kidney tubulointerstitium is relatively protected whereas no infiltration of the kidneys of RIP-mOVA
against CD8 T-cell infiltration by a mechanism mice could be observed (Table 1 and Figs. 1D and 2A).
distinct from CD95 signaling Kidney infiltration also was not observed when mice were
analyzed earlier (day 3 after adoptive transfer) or laterRIP-mOVA mice express the model autoantigen, mem-
brane-bound ovalbumin (mOVA) in pancreatic  cells (day 14) or when up to 20  106 OT-I cells were used
(data not shown). Nontransgenic recipient mice showedand kidney proximal tubular cells [15]. When naive
OVA-specific CD8 T cells (OT-I cells) from the trans- neither islet (Fig. 1A) nor kidney infiltration (Fig. 1B).
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Table 1. Lack of kidney infiltration by naive autoreactive Infiltration and damage of the intact kidney
CD8 T cells
tubulointerstitium by in vitro-activated
Kidney autoreactive CD8 T cells
Pancreatic islet tubulointerstitial
In contrast to the naive OT-I cells used in the experi-Group infiltration infiltration
ments described previously in this article, previous studiesNaive OT-I, RIP-mOVA 15/15 0.10.3
Naive OT-I. nontg, LN 0/4 0 examining T-cell–mediated nephritis used CD8 T cells
Naive OT-I.lpr, RIP-mOVA 4/4 0.20.4 of an activated phenotype, for example, from T-cell lines.
Naive OT-I.lpr, nontg. LN 0/2 0
These studies found tubulointerstitial infiltration by suchNaive OT-I.129, RIP-mOVA 11/11 0.50.8
Naive OT-I.129, nontg. LN 0/2 0 cells under certain conditions. To investigate whether
Activated OT-I, RIP-mOVA 9/9 2.61.5 OT-I cells in an in vitro activated state could also infil-
Activated OT-I, nontg. LN 0/5 0.40.5
trate the kidney, we cocultured naive OT-I cells with
Abbreviations are: OT-I, ovalbumin-specific CD8 T cells; mOVA, mem-
antigen-pulsed cells from a syngeneic spleen as a sourcebrane-bound ovalbumin; nontg., nontransgenic; LN, renal lymph node; RIP, rat
insulin promoter. of professional APCs. After five days, 10 106 activated
OT-I cells were injected intravenously into RIP-mOVA
mice. This experiment was performed four times in
groups of two to three animals. After two to three days,
We have recently shown that OT-I cells derived from nine of nine mice had developed glucosuria and showed
mice backcrossed to CD30 knockout mice carried founder infiltration and complete destruction of pancreatic islets
129 genes that allowed enormous proliferation of these (data not shown). In the kidney, varying degrees of tubu-
OT-I.129 cells in response to autoantigen [18]. Transfer lointerstitial infiltration were observed, ranging from no
of as few as 160 of these OT-I.129 cells, 104-fold less than visible infiltrate in two animals to dense mononuclear
required for wild-type OT-I cells, was able to induce infiltration of the whole cortex with severe tubulitis in
diabetes in RIP-mOVA mice [18]. All recipients dis- three mice (Table 1). These cells were CD8 cells (like
played glucosuria, diabetic polyuria, and complete de- OT-I cells) and were located next to the mOVA-express-
struction of pancreatic islets accompanied by a prominent ing tubules (Fig. 2A). Control sections of RIP-mOVA
lymphocytic infiltrate even in the exocrine part of the mice injected with naive OT-I cells showed only sporadic
pancreas (Fig. 1F and Table 1). However, even transfer CD8 T-cells (Fig. 2B), as did sections of nontransgenic
of 5  106 of these much more autoaggressive OT-I.129 mice injected with naive or activated OT-I cells (data
not shown). No T-cell infiltration was observed in organscells resulted in only a small-to-moderate kidney infil-
of RIP-mOVA mice that did not express OVA such astrate in 4 of 11 recipients (Fig. 1E and Table 1). CD30-
the liver or in the kidneys of nontransgenic recipients. Indeficient OT-I cells lacking the 129-derived genes did
infiltrated kidneys, the OVA expression of the transgenicnot show an increased ability to cause autoimmune de-
tubules appeared less intense in infiltrated kidneys thanstruction (data not shown), indicating that CD30 signal-
in kidneys from mice injected with naive OT-I cells,ing did not mediate the increased autoaggression of the
suggesting that the infiltrating OT-I cells had damagedOT-I.129 cells.
the antigen-expressing tubuli. Consistent with this obser-These data suggested that the kidney tubulointersti-
vation, some recipient mice developed complete anuriatium is more protected from T-cell–mediated damage
on day 4 to day 6 after glucosuria, depending on thethan pancreatic islets. Such protection is a hallmark of
number of activated OT-I cells injected, suggesting thatso-called immunoprivileged sites. Recently, CD95L ex-
the injected OT-I cells had induced acute renal failurepression in these sites has been proposed to be responsi-
by destroying the proximal tubules of the recipient mice.
ble for this immunoprivileged state [9]. To investigate
To examine such tubulointerstitial damage mediated
whether this mechanism also operates in the kidney, by OT-I cells in more detail, the kidneys of a group of
we generated OT-I cells deficient in CD95 signaling by RIP-mOVA mice injected with 10  106 activated OT-I
crossing OT-I mice with MRL/lpr mice, which carry a cells were analyzed at later time points. To account for the
mutation in the CD95 gene. The resulting OT-I.lpr mice observed great variability of infiltration in the individual
produced OVA-specific CD8T cells, which are resistant mice, the two kidneys from one recipient mouse were
to CD95L-mediated death signals, but are activated and examined separately at different time points. The left
proliferate to the same extent as OT-I wild-type cells kidney was removed two days after onset of glucosuria,
[17]. Transfer of OT-I.lpr cells led to infiltration of the and the second kidney was taken after two further days.
pancreatic islets (Fig. 1E) and caused diabetes mellitus, Histological analysis showed focal tubulointerstitial in-
demonstrating that OT-I.lpr cells were fully able to per- filtration and some tubular atrophy in the cortex on day
form effector functions. In the kidney, however, no infil- 3 after glucosuria (Fig. 2C). This tubular atrophy was
more pronounced on day 5, whereas the tubulointersti-tration could be observed (Table 1 and Fig. 1F).
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Fig. 2. Tubulointerstitial infiltration and damage by in vitro-activated OT-I cells. Ten  106 in vitro-activated OT-I.RAG/ cells (A) or the same
number of naive OT-I.RAG/ cells (B) were injected intravenously into RIP-mOVA mice. When glucosuria was detected, the recipient mice
were sacrificed, and kidney frozen sections were stained by two-color immunofluorescence for ovalbumin (green) and CD8 (red). Magnification
200. Ten  106 (C and D) or 1  106 (E and F ) in vitro-activated OT-I cells were injected intravenously into RIP-mOVA mice. On the second
day after glucosuria was detected, three of the five mice injected with 10  106 OT-I cells had become anuric. At this stage, the recipient mice
were unilaterally nephrectomized as described (C and E) [15]. Two days later, the animals were sacrificed, and the remaining kidney was taken
(D and F). Paraffin sections were stained for hematoxylin and eosin. Magnification 200.
tial infiltration had not increased (Fig. 2D and Table 2). mice produced only a little urine, and it contained blood
and protein. In contrast, RIP-mOVA mice injected withConsistent with this histological picture, three of the
five mice of this group had become completely anuric naive OT-I cells always remained polyuric due to diabe-
tes mellitus, but never became anuric. Three nontrans-between day 3 and day 5 after glucosuria. The other two
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Table 2. Kinetics and T cell dose-dependence of kidney infiltration
Kidney
Pancreatic islet tubulointerstitial
Group Day infiltration infiltration
10106 OT-I 3 NA 2.81.3
10106 OT-I 5 5/5 2.81.6
1106 OT-I 3 NA 2.00.8
1106 OT-I 5 4/4 1.00.8
Abbreviations are: OT-I, ovalbumin-specific CD8 T cells; NA, not applica-
pable.
genic control mice injected with the same number of
activated OT-I cells and unilaterally nephrectomized did
not show glucosuria, anuria, or tubulointerstitial infiltra- Fig. 3. Apoptosis of the infiltrating T cells. Ten 106 in vitro-activated
tion (data not shown). OT-I cells were injected intravenously into RIP-mOVA mice. On day
5 after glucosuria was detected, kidney paraffin sections were stainedWhen the same kinetic analysis was performed in mice
by the TUNEL technique for apoptotic cells. A 400 magnificationinjected with only 1 106 activated OT-I cells, the tubulo- of the tubulointerstitial infiltrate, which contained apoptotic cells iden-
interstitial infiltrate on day 3 was smaller than in those tified by a black nucleus, is shown.
animals injected with tenfold the number of OT-I cells
(Fig. 2E and Table 2). All of the four mice of this group
developed glucosuria and polyuria, but none became
they can be deleted [16]. The present study demonstratesanuric. On day 5, some focal tubulointerstitial damage
that under these conditions, autoimmune nephritis didwas visible (Fig. 2F), whereas the tubulointerstitial infil-
not result, indicating that kidney proximal tubules aretrate was smaller than on day 3 (Table 2). Because of
relatively protected against infiltration by autoreactivediabetic wasting, animals were not kept longer than five
CD8 T cells as compared with pancreatic islets. Evendays after the initial onset of glucosuria.
when we used autoreactive CD8 T cells with a 104-foldTo examine whether the apparent reduction of the tubu-
diabetogenic potential, only a moderate infiltration waslointerstitial infiltrate was due to apoptosis of the infiltrat-
evident, suggesting that the protective mechanism musting cells, we employed the TUNEL technique to examine
be very efficient.kidney sections of two of the previously mentioned mice
This finding supports observations in the anti-TBMinjected with 10 106 activated OT-I cells that displayed
and HBsAg mouse models, in which CD8 T cells spe-large infiltrates. On day 3 after injection, there were only
cific for tubular antigens failed to infiltrate the kidneyfew apoptotic cells within the infiltrate (5%). On day
of susceptible recipient mice after intravenous injection5, approximately 20 to 30% of the infiltrating OT-I cells
[5, 7, 8]. In both studies, kidney tissue damage allowedwere apoptotic (Fig. 3). In mice injected with only 1 106
local T-cell infiltration, suggesting that structural fea-activated OT-I cells, only few apoptotic cells were visible
tures of the kidney architecture, such as the dense TBM,within the small infiltrate (data not shown).
might sequester CD8 T cells from the undamaged tubu-
lointerstitial compartment. Alternatively, it was suggested
DISCUSSION that undamaged tubular cells might express insufficient
antigen or MHC class I molecules, and only local inflam-This study used the transgenic RIP-mOVA model to
examine the effector phase of autoreactive CD8 T cells matory reactions to the transrenal puncture might up-
regulate these molecules for recognition by CD8 T cells.against a renal tubular self-antigen. In contrast to previ-
ous studies that used T cells of an activated phenotype, In the present study, activated OT-I cells and OT-I.129
cells carrying genes originating from the mouse strainthe RIP-mOVA model allows the use of naive T cells.
This reflects the normal situation more closely in which 129 infiltrated the undamaged kidney in some recipient
mice, demonstrating that the renal tubulointerstitium isnaive T cells are activated by self antigens in vivo, which
is of critical importance for understanding of how auto- not completely inaccessible to autoreactive CD8T cells,
and that undamaged tubuli can express sufficient antigenimmunity may be initiated. The activation of autoreac-
tive CD8 T cells was facilitated by professional APCs and MHC class I to be detected by CD8 T cells. Thus,
the proposed anatomical or functional sequestration ofcross-presenting pancreas/kidney-derived autoantigens
in the pancreatic/renal LN [15]. This form of activation the tubular compartment cannot be complete, and other
mechanisms have to be considered.of autoreactive CD8 T cells normally leads to immune
tolerance by deletion [16]. However, very high numbers One such mechanism would be CD95L-mediated apo-
ptosis of infiltrating T cells. In allograft rejection, thisof these cells can induce autoimmune diabetes before
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mechanism has recently been proposed to mediate the of 10 106 in vitro-activated OT-I cells, suddenly, a very
immunoprivileged state of the eye and the kidney [9]. large number of OT-I effector cells were available to
Also, kidney proximal tubules have been shown to ex- infiltrate the pancreas and the kidney of RIP-mOVA
press CD95L in vitro [13, 14] so that, theoretically, apo- mice and destroy all antigen-bearing tissue cells. This was
ptosis of OT-I cells might be induced before these cells reflected by the faster onset of diabetes after injection of
could accumulate to a visible infiltrate. In the absence activated OT-I cells (2 to 4 days as compared with 5 to
of such an infiltrate, it was impossible to demonstrate 9 days after injection of naive T cells). These cells might
directly such apoptosis in our system using histological cause sufficient kidney damage before their lifespan was
techniques. Therefore, we generated CD95L-deficient exhausted. Consistent with this interpretation, the ob-
OT-I cells, which are resistant to CD95L-mediated sig- served apoptosis of activated OT-I cells was detectable
nals [17]. However, these cells failed to infiltrate the mainly at later time points. If this hypothesis was true,
kidneys of RIP-mOVA mice, ruling out a contribution then lower numbers of activated OT-I cells should not
of this hypothetic pathway to the observed protection in cause kidney failure because their lifespan would end
our system. This finding does not exclude that other, yet before they could destroy the tubulointerstitium com-
unidentified, mediators induce apoptosis of OT-I cells. pletely. This prediction was verified by our present experi-
The previously mentioned mechanisms of organ pro-
ments using lower numbers of activated OT-I cells. These
tection against T-cell infiltration, that is, sequestration
cells infiltrated the kidney and caused some focal damage,and CD95-ligand induced apoptosis, are both mediated
but then disappeared without causing acute renal failure.by the kidney tissue. Alternatively, the T-cell phenotype
These considerations support the importance of kineticmight influence the different nephritogenicity of naive
differences in the T effector cell availability, but they doversus activated OT-I cells. In support of this hypothesis,
not rule out a role of different T-cell phenotypes.T-cell lines with different levels of nephritogenicity have
One physiological rationale of the relative protectionbeen described in the anti-TBM model. Several TBM-
of proximal kidney tubules against T-cell–mediated dam-specific CD8 T-cell lines differed in their ability to infil-
age may relate to their ability to reabsorb proteins fromtrate the kidney after subcapsular injection [7], suggesting
the tubular lumen and blood [23, 24]. During virus infec-that CD8 T cells might be able to differentiate into
tions, viral proteins are often released from infected bodyeffector cells with varying nephritogenicity. In the pres-
cells, in particular by virus-specific CD8 T cells thatent study, OT-I cells activated in vitro might have as-
have initiated an antiviral immune response. Such viralsumed a functional state that rendered them resistant to
protective mechanisms in the kidney, whereas OT-I cells proteins might be reabsorbed and presented by MHC
activated by cross-presentation in vivo might have differ- class I molecules of kidney tubular cells. If not for their
entiated into cells unable to infiltrate the kidney. Such relative protection, these tubules might also become tar-
an activation mechanism may protect the kidney from gets for destruction by anti-viral CD8 T cells. Indeed,
autoimmune damage by CD8 T cells specific for renal tubular cells were shown to present soluble antigens in
autoantigens. Phenotypical differences between naive vitro [25–27] and in vivo [28], albeit to CD4 T-cell clones
and in vitro activated T cells also imply that experiments or hybridomas that, however, have reduced requirements
with T-cell lines injected into experimental animals have for costimulatory signals as compared to naive T cells
to be interpreted with great caution because such lines [29, 30]. Whether tubular cells are also able to cross-
may not act in every aspect like T cells activated in vivo. present reabsorbed proteins to CD8 T cells must await
Alternatively, the ability of in vitro activated OT-I further investigation.
cells to infiltrate the kidney might be explained by kinetic In summary, we have established a transgenic model
differences in the availability of OT-I effector cells. We
to investigate the response of CD8 T effector cells
have recently shown that the onset of autoimmune diabe-
against a kidney tubular self-antigen in vivo. Using thistes in the RIP-mOVA model is strictly dependent on
model, we have demonstrated protection of the kidneythe number of OT-I cells [16]. Likewise, the kidney infil-
tubular compartment against CD8T-cell–mediated auto-tration may depend on the number of available OT-I
immunity that did not only depend on previously de-effector cells. To gain effector functions, naive OT-I cells
scribed, kidney-specific parameters, such as anatomicalfirst need to be activated. Experiments with fluorescently
barriers or expression of MHC class I or CD95L. In ourlabeled OT-I cells demonstrated a large proportion of
model, T-cell parameters such as their phenotype ornaive cells even after seven days (Kurts, unpublished
number also played an important role in governing tis-findings), suggesting that the activation of 10 106 naive
sue-specific T-cell–mediated autoimmunity. These find-OT-I cells might take more than a week. Thus, only a
ings support a model of several levels of protectionsmall number of OT-I effector cells will be available at
against autoimmunity, which include not only parame-a given time point because effector T cells generally have
a limited lifespan [16, 21, 22]. In contrast, after injection ters of the target organ, but also of the effector cell [31].
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